Neoxpert Expanded Screening Panel Test (Newborn Screening 48+ Analytes) in T Nagar
51+ booked in last 3 daysTest Overview
Newborn babies may be afflicted by a variety of conditions including cystic fibrosis, hereditary disorders, haemoglobinopathies, and inherited metabolic disorders (IMDs) from birth. IMDs are brought on by a gene abnormality that causes an enzyme deficit. Therefore, screening is crucial to identify potential fetal problems in newborns as quickly as possible, well before they show any symptoms of the disorder. Early diagnosis enables prompt treatment, which lessens the condition's negative effects.Newborn screening offers one such comprehensive screening method.
NBS, or newborn screening, is commonly referred to as the "baby's first test." Many newborn babies have a minor heel puncture around day two through either voluntary or required programs, and a few drops of blood are collected. This is sent to a diagnostic lab to examine for more than 40 extremely rare illnesses known as inborn metabolic errors. Aminoacidopathies, organic acidemias, fatty acid oxidation disorders, galactosemia, and biotinidase deficiency are among the conditions that can be detected with NBS.
Medically Reviewed by: Dr Alap Christy, MBBS, MD, PGDM-HC, Dept. of Clinical Chemistry
Neoxpert Expanded Screening Panel Test (Newborn Screening 48+ Analytes) Price in Chennai
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Neoxpert Expanded Screening Panel Test (Newborn Screening 48+ Analytes) with a clear pricing structure
The price of Neoxpert Expanded Screening Panel Test (Newborn Screening 48+ Analytes) in Chennai is ₹ 6,420
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
To identify babies at-risk for various inborn errors of metabolism.
This is a screening test for newborn babies usually done within 48-72 hours of birth to detect inborn errors of metabolism.
Newborn Screening is a test that involves testing of infants at birth for certain genetically linked metabolic disorders which may affect baby’s physical, mental and intellectual development. This is a combined panel which tests for 8 analytes viz TSH, G6PD and 17-OHP, Phenyl Alanine, Cystic Fibrosis, Galactosemia, Biotinidase and MSUD by FIA technology. This panel also tests for various analytes using Tandem Mass Spectrometry (TMS) that enables detection of multiple metabolic disorders with a single sample. Disorders that can be detected using TMS are various types of fatty acid, amino acid and organic acid related disorders.
How it Works?
All our phlebotomists are vaccinated
At Metropolis Healthcare, your well-being is our top priority. Rest assured, all our skilled phlebotomists are vaccinated, ensuring a safe and secure experience for you. Our team upholds the highest healthcare standards, and your health is in capable hands. Your safety is non-negotiable, and at Metropolis, we take every measure to guarantee it.
Our Phlebotomists maintain a high standard of safety precautions
Our dedicated team of phlebotomists prioritises your safety before anything else. They implement stringent safety measures to guarantee your well-being during their visit.
Strictly adhering to aseptic techniques, our phlebotomists maintain a sterile environment with thorough sanitization and the use of gloves, masks and face shields. Needles are disposed of with utmost care, following rigorous guidelines to minimise any potential risks. We leave no room for compromise when it comes to personal protective equipment (PPE), ensuring both you and our staff are well protected.
Our phlebotomists collect samples safely
The phlebotomists at Metropolis Healthcare are proficient in safe sample collection. They skillfully and gently draw blood, minimizing any discomfort you may feel. We prioritize your safety by using sterile, single-use needles and barcoded vials to completely eliminate any risk of cross-contamination. Our collection area is carefully sanitized before, during, and after your sample collection.
Samples are processed at high-tech facilities
Metropolis Healthcare takes pride in its state-of-the-art facilities, where your samples are thoroughly processed. Our labs are equipped with cutting-edge machinery with advanced technology, eliminating chances of human error. From the moment your sample arrives at our facility, it undergoes an automated process.
Your samples are stored in clean and secure facilities
We leave no room for compromise when it comes to the storage of your samples. Our storage facilities are regularly cleaned and disinfected, upholding the highest standards of healthcare safety.
Temperature-controlled environments and cooling facilities ensure that your samples remain fresh and the results produced are accurate. Our cutting-edge security measures prevent unauthorized access, guaranteeing the confidentiality of your health data.
Metropolis provides accurate digital reports
Our advanced sample processing machines not only deliver swift results to you but also generate precise digital reports. We provide conclusive diagnoses through meticulous re-checks and repeat specimen analyses, if required, at no extra cost, adding an extra layer of accuracy and dependability. This unique approach sets us apart, earning the trust of top doctors and hospitals across the country.
Your health is our priority, and we spare no effort in our commitment to providing you with the most accurate insights you can rely on.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.